Kyntra Bio, Inc. KYNB
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Return on equity has no reading this year — return on capital employed, just below, still does: -53%.
The 13-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 |
| Operating income $B | −0.0 | −0.2 | −0.3 | −0.3 | −0.3 | −0.2 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 |
| EBITDA $B | −0.0 | −0.1 | −0.3 | −0.3 | −0.3 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 | −0.1 | −0.0 | −0.0 |
| Income tax $B | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.2 | −0.0 | −0.3 | −0.3 | −0.3 | −0.2 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 |
| Free cash flow $B | −0.0 | −0.1 | −0.3 | −0.1 | −0.1 | 0.1 | −0.1 | −0.1 | −0.1 | 0.0 | −0.0 | 0.0 | 0.0 |
| EPS, diluted $ | 45.37 | −11.89 | −2.92 | −3.14 | −3.14 | −2.11 | −0.89 | −1.03 | −1.66 | −0.93 | −1.42 | −3.17 | −1.13 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | — | — | — | — | −91.9 | −40.3 | −15.0 | −16.7 | −35.3 | −34.8 | −43.0 | — | — |
| Shares out B | 0.00 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.06 | 0.06 | 0.06 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 13 of the 13 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. 12 checks were skipped: cost of revenue is not tagged before 2019. Six checks were skipped: EPS is not tagged before 2013.